Aurora Files Preliminary Base Shelf Prospectus TSX: ACB | NYSE: ACB Provides Flexibility to Execute on Aurora's Global Expansion and Partnering Strategy EDMONTON

Aurora Files Preliminary Base Shelf Prospectus

TSX: ACB | NYSE: ACB

Provides Flexibility

to Execute on Aurora's Global Expansion and Partnering Strategy

EDMONTON, April 2, 2019 /CNW/ - Aurora Cannabis

Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that

it has filed a preliminary short form base shelf prospectus (the "Shelf Prospectus") with the securities regulators in

each province of Canada, except for the Province of Quebec, and a corresponding shelf registration statement on Form F-10

(the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC").

"Although we have no immediate intention

of drawing capital against this Shelf Prospectus, we have introduced this option as a prudent and long-term strategic measure to

provide us with flexibility in access to growth capital, if or when required, to continue executing on our global expansion and

partnering strategy," said Michael Singer, Executive Chairman. "With our recent listing on the NYSE, our successful financing

in January 2019 led by U.S. institutional investors, and as we work with Nelson Peltz to explore potential partnership opportunities,

this filing is a natural evolution for our company as we rapidly mature into a global and profitable organization."

The Shelf Prospectus and Registration Statement,

when made final or effective, will allow the Company to make offerings of common shares, debt securities, subscription receipts,

units, warrants or any combination thereof of up to US$750 million during the 25 month period that the Shelf Prospectus is effective.

Should the Company decide to offer securities during this period, the specific terms, including the use of proceeds from

any offering, will be set forth in a related prospectus supplement to the Shelf Prospectus, which will be filed with the applicable

Canadian securities regulatory authorities and the SEC.

The Company is also considering the use of

the Shelf Prospectus and subsequent prospectus supplement to allow for an "at the market distribution" in accordance

with applicable securities laws. An at-the-market distribution provides for securities to be sold by registered dealers on

behalf of the Company through the stock exchange at prevailing market prices at the time of sale. Currently, no agreement

has been entered into for an at-the-market distribution.

A copy of the Shelf Prospectus can be found

on SEDAR at www.sedar.com and a copy of the Registration Statement can be found on EDGAR at www.sec.gov.

The Registration Statement has been filed with

the SEC but has not yet become effective. No securities may be sold nor may offers to buy be accepted prior to the time the Registration

Statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor

shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior

to registration or qualifications under the securities laws of any such jurisdiction.

Headquartered in Edmonton, Alberta, Canada

with funded capacity in excess of 500,000 kg per annum and sales and operations in 24 countries across five continents, Aurora

is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across

every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis

and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.

Highly differentiated from its peers, Aurora

has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate

leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale

production of high quality product at low cost. Intended to be replicable and scalable globally, our production facilities are

designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs.

Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf

Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland have achieved this level of certification.

In addition to the Company's rapid organic

growth and strong execution on strategic M&A, which to date includes 16 wholly owned subsidiary companies - MedReleaf,

CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses,

CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs and Whistler - Aurora is

distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established

strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber

Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium

Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ)

and High Tide Inc. (CSE:HITI).

Aurora's Common Shares trade on the NYSE and

TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.

For more information about Aurora, please visit

our investor website, investor.auroramj.com

Aurora Cannabis Inc.

Forward looking statements

This news release includes statements containing

certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").

Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",

"project", "intend", "believe", "anticipate", "estimate", "may", "will",

"potential", "proposed" and other similar words, or statements that certain events or conditions "may"

or "will" occur and include, but are not to, statements regarding the filing and effectiveness of the final Shelf Prospectus

and Registration Statement, the filing and effectiveness of any potential prospectus supplement; the amount and terms of any securities

to be offered, and anticipated timing of any financing under the final Shelf Prospectus and Registration Statement. These statements

are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking

statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the

date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual

events or results to differ materially from those projected in the forward-looking statements. including but not limited to, the

timing and filing of the final Shelf Prospectus; the potential offering of any securities by the Company; uncertainty with respect

to the completion of any future offering; the ability to obtain applicable regulatory approval for any contemplated offerings;

the ability of the Company to negotiate and complete future funding transactions, as well as the risks identified under the heading

Risk Factors in our Annual Information Form for the fiscal year ended June 30, 2018. The Company is under no obligation,

and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of

new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider

(as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this

original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-files-preliminary-base-shelf-prospectus-300823511.html

SOURCE Aurora Cannabis Inc.

View original content to download multimedia:

For further information: For Media: Heather MacGregor, +1.416.509.5416,

heather.macgregor@auroramj.com; For Investors: Marc Lakmaaker, +1.647.269.5523, marc.lakmaaker@auroramj.com; Rob Kelly, +1.647.331.7228,

rob.kelly@auroramj.com; U.S. Investors: Phil Carlson / Elizabeth Barker, KCSA Strategic Communications, Phone: (212) 896-1233 /

(212) 896-1203, Email: pcarlson@kcsa.com / ebarker@kcsa.com

CO: Aurora Cannabis Inc.

CNW 19:59e 02-APR-19